Most lately, it's been determined that conolidine and the above derivatives act on the atypical chemokine receptor three (ACKR3. Expressed in related spots as classical opioid receptors, it binds to some big range of endogenous opioids. Compared with most opioid receptors, this receptor acts as a scavenger and will not activate a second messenger p